Scientific events
Three posters on the anti-KIR program to be presented at the upcoming ASH annual meeting
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class drug candidates for cancer and inflammatory diseases, announces today that three posters on...